AstraZeneca has rejected Pfizer's sweetened takeover bid, describing the proposed $106 billion deal as inadequate.
Showing posts with label AstraZeneca. Show all posts
Showing posts with label AstraZeneca. Show all posts
Subscribe to:
Posts (Atom)